Aciclovir Dosage Strengths for Cold Sore Treatment
Standard Aciclovir Tablet Strengths
Aciclovir tablets are available in three main strengths: 200mg, 400mg, and 400mg. For cold sore treatment, the 400mg strength is most commonly prescribed by healthcare providers. The 400mg tablets offer an optimal balance between effectiveness and dosing convenience, typically requiring five doses daily during active outbreaks.
Treatment vs Prevention Dosages
The dosage of aciclovir varies significantly depending on whether you're treating an active cold sore outbreak or preventing future episodes. For treating active cold sores, adults typically take 400mg five times daily for five days, starting as soon as symptoms appear. This higher frequency helps reduce the duration and severity of the outbreak when treatment begins early.
For suppressive therapy in people who experience frequent outbreaks (six or more per year), lower maintenance doses are used. This typically involves 400mg twice daily, though some patients may require different dosing schedules based on their individual response and outbreak frequency.
Alternative Antiviral Options
Valaciclovir 500mg tablets provide an alternative to aciclovir with more convenient dosing. Valaciclovir is converted to aciclovir in the body but has better absorption, allowing for less frequent dosing. The typical dose is 500mg twice daily for five days for treatment, or once daily for suppressive therapy.
EverydayMeds stocks both aciclovir 400mg tablets and valaciclovir 500mg options, allowing patients to access the most suitable treatment for their needs through our online consultation service.
Timing and Effectiveness
The effectiveness of cold sore treatment depends heavily on when treatment begins. Starting antiviral tablets at the first sign of tingling or prodromal symptoms can significantly reduce the outbreak's severity and duration. Delaying treatment until blisters have fully formed may reduce the medication's effectiveness.
It's important to complete the full course of tablets even if symptoms improve quickly. Stopping treatment early may allow the virus to reactivate and could potentially lead to treatment resistance.
